Clinical study to see the effect of Tinospora cordifolia in acute ischemic stroke patients.

Study the clinical, biochemical, genetic and radiological profile of cerebral small vessel disease and to investigate the clinical improvement in ischemic stroke patients by Tinospora cordifolia through blinded randomized control trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/11/029182

Enrollment

300

Registered

2020-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G810- Flaccid hemiplegia

Interventions

Intervention1: Tinospora cordifolia: Its an ayurvedic herb. We are using it as an additive treatment in treatment group along with standard medication in both the groups (treatment group and placebo g

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years 2. Cases of Ischemic stroke with and without periventricular white matter changes.

Exclusion criteria

Exclusion criteria: 1. Patients denying the consent to participate. 2. Traumatic brain injury, vascular aneurysm, arterial malformation, etc. 3. History of Central Nervous System (CNS) infections. 4. Recurrent ischemic stroke

Design outcomes

Primary

Measure	Time frame
Functional Outcome (mRS)Timepoint: 0 days and at 90 days	—

Secondary

Measure	Time frame
NIHSS, MoCA, Clinical Dementia Rating (CDR)Timepoint: 0 days and 90 days	—

Countries

India

Contacts

Public ContactDr Abhishek Pathak

Institute of Medical Sciences

abhishekpathakaiims@gmail.com7499904491

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026